Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
4.020
+0.010 (0.25%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $19.31 million as of October 23, 2026. It is the 37,194th most valuable company in the world and the 5,223rd biggest in the United States. Its market cap has increased by 164.55% in one year.
Market Cap
19.31M
Enterprise Value
10.54M
1-Year Change
164.55%
Global Rank
Country Rank
#5,223 United States
Category
ChartMarket Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $19.31M, a decrease of -80.12%. That is a compound annual growth rate of -27.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 19.31M | 59.52% |
| Dec 31, 2025 | 12.11M | 127.24% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
| Oct 29, 2021 | 97.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 21.65M |
| NextCure | 21.61M |
| Seres Therapeutics | 21.40M |
| Polyrizon | 21.18M |
| Kyntra Bio | 21.14M |
| Neuphoria Therapeutics | 18.83M |
| Akari Therapeutics, | 18.51M |
| Quantum BioPharma | 18.36M |